Sign up
ABOUT IPC
Vision and Mission
Board of Directors
Member Owned Cooperative
Legislative
Distribution Center
100% Rebate Return
Pharmacy Select
Pharmacy Profiles
Community Events
Careers
WHAT WE OFFER
Brand Rx
Generic Rx
Rx Promotions
OTC Products
OTC Promotions
Contracted Vendors
GOVT. RELATIONS & NEWS
National Updates
State Updates
IPC Legislative Action Center
State Legislative Tracking
Capitol Agenda
Newsletter
MEMBERSHIP OPTIONS
How to Apply
CONTACT US
Log in to order
Log in
Forgot Login Info?
Join Now
IPC Member Benefits
Join Now
Rx Brand Advantage
offers 500+ items at cost -3.00% or better.
Rx Generics
with savings as high as 30% and weekly specials.
OTC profit makers
and hot merchandising programs.
Access to 40+
vendor programs
that perform.
Government Relations
team at work for you.
Login ID
Email address
Reset Password
Government Relations
& News
Govt. Relations - National Updates
Read All National Updates >
ACA Repeal and Replace Is Uncertain, But Plenty Happening in DC On Prescription Drug Cost Issues
Jul 21, 2017
While the prospect of repealing and replacing the Affordable Care Act remains uncertain in Congress, there are other federal legislative activities that impact pharmacy that IPC has been actively engaged in, especially as it relates to drug price increases and the role of PBM’s.
The Pharmacy and Medically Underserved Areas Enhancement Act of 2017 a Priority for IPC’s Advocacy Team
Jul 17, 2017
The Pharmacy and Medically Underserved Areas Enhancement Act of 2017 introduced as S.109 and H.R. 592 continues to be a priority for IPC’s advocacy team. The legislation would allow pharmacists to bill for Medicare Part B services and would enhance access to healthcare in many areas of the country. IPC has met with numerous Congressional members to express support for this much needed change in reimbursement for pharmacy provided services.
At IPC request, Sen. Bennet (D-CO) Submits Provider Status Question as part of Senate Finance Committee Confirmation Hearing for HHS Nominee
Jan 31, 2017
Rep. Tom Price (R-Ga.), President Trump's nominee to lead the Department of Health and Human Services (HHS) testified this week before the Senate Finance Committee. The Senate Finance Committee is set to vote on the HHS nominee this week.
Govt. Relations - State Updates
Read All State Updates >
IPC California Members: Distributors of Nonprescription Diabetes Test Devices Posted Online
Aug 21, 2017
As required by AB 602 (Bonta, Chapter 139, Statutes of 2017), a list of names of authorized distributors of nonprescription diabetes test devices is now posted on the California State Board of Pharmacy website.
IPC Pennsylvania Members: Urge Your State House Representative to Support HB 1595
Jul 07, 2017
IPC has been working closely with other Pennsylvania pharmacy industry stakeholders, including the Pennsylvania Pharmacists Association (PPA), to monitor Pennsylvania Medicaid's development of a new federally mandated fee-for-service (FFS) prescription reimbursement formula designed to reflect transparent "true cost" to provide Medicaid patients with access to their prescription drug benefit.
IPC Ohio Members: Update! Ohio Budget Contains Tiered Fee for Medicaid Prescriptions
Jul 06, 2017
IPC has learned that the final version of the Ohio State Annual Appropriations Act signed into law by Ohio Governor John Kasich (R) contained the Senate version which allows Medicaid to move forward with its proposed four (4) tiered, volume based dispensing fee rather than the House proposed flat fee of $10.49.
Learn More
Legislative Action Center
State Legislative Tracking
Capitol Agenda
IPC Newsletter
